WallStreetZenWallStreetZen

NASDAQ: ROIV
Roivant Sciences Ltd Stock Ownership - Who owns Roivant Sciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Roivant Sciences Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Eric VenkerPresident COO2025-04-21100,000$10.22
$1.02MSell
Eric VenkerPresident COO2025-04-21100,000$3.85
$385.00kBuy
Eric VenkerPresident COO2025-04-2010,945$10.15
$111.09kSell
Matthew GlineCEO2025-04-2010,945$10.15
$111.09kSell
Ilan OrenDirector2025-04-1764$10.15
$649.60Sell
James C. MomtazeeDirector2025-04-17276$10.15
$2.80kSell
Richard PulikCFO2025-03-281,653$10.38
$17.16kSell
Eric VenkerPresident COO2025-03-24434,478$10.82
$4.70MSell
Eric VenkerPresident COO2025-03-24602,311$3.85
$2.32MBuy
Richard PulikCFO2025-03-201,504$10.97
$16.50kSell

1 of 11

ROIV insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ROIV insiders and whales buy or sell their stock.

ROIV Shareholders

What type of owners hold Roivant Sciences Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Daniel Allen Gold26.05%185,902,551$2.10BInsider
Qvt Financial LP21.85%155,900,768$1.76BInsider
Dexcel Pharma Technologies Ltd14.41%102,849,443$1.16BInsider
Keith S. Manchester13.27%94,687,658$1.07BInsider
Svf Investments Uk Ltd10.23%73,031,667$824.53MInsider
Sumitomo Chemical Co Ltd9.99%71,251,083$804.42MInsider
Qvt Financial LP9.22%65,793,779$742.81MInstitution
Sb Investment Advisers Uk Ltd8.70%62,057,537$700.63MInstitution
Vivek Ramaswamy7.49%53,431,427$603.24MInsider
Fmr LLC6.91%49,301,583$556.61MInstitution

1 of 3

ROIV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ROIV41.16%58.84%Net SellingNet Buying
TECH97.63%2.37%Net BuyingNet Selling
CORT30.22%69.78%Net BuyingNet Buying
HALO78.14%21.86%Net SellingNet Selling
RVMD90.68%9.32%Net BuyingNet Selling
View Top Biotech Stocks

Roivant Sciences Stock Ownership FAQ

Who owns Roivant Sciences?

Roivant Sciences (NASDAQ: ROIV) is owned by 78.82% institutional shareholders, 112.66% Roivant Sciences insiders, and 0.00% retail investors. Daniel Allen Gold is the largest individual Roivant Sciences shareholder, owning 185.90M shares representing 26.05% of the company. Daniel Allen Gold's Roivant Sciences shares are currently valued at $2.16B.

If you're new to stock investing, here's how to buy Roivant Sciences stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.